Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis A Farraye

Showing results (301-310 of 432) with videos related to

Pageof 44
Sort By:
Annals of Gastroenterology|July 3, 2023
Association of serum IgG4 and disease outcomes in patients with inflammatory bowel diseaseR Christopher Chase, Hani Tamim, Walaa G El Sheikh, et al.
Gastro Hep Advances|September 23, 2024
Frailty and Inflammatory Bowel Disease: A Nationwide AssessmentYassine Kilani, Saqr Alsakarneh, Mohammad Aldiabat, et al.
Digestive Diseases and Sciences|June 14, 2025
Patients with Crohn's Disease and Ileostomy Can Respond to UpadacitinibLauren Loeb, Francis A Farraye, Sheena Crosby, et al.
The American Journal of Gastroenterology|February 6, 2024
Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial VirusRyan A Smith, Aakash Desai, Edward L Barnes, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 20, 2011
Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosisMelanie L Gainsbury, Daniel I Chu, Lauren A Howard, et al.
The American Journal of Surgical Pathology|March 27, 2004
Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findingsJonathan N Glickman, Athos Bousvaros, Francis A Farraye, et al.
Alimentary Pharmacology & Therapeutics|June 24, 2021
The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programmeFrancis A Farraye, Taha Qazi, Paulo G Kotze, et al.
Cancer|August 14, 2002
Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escapeWolfram V Bernstorff, Jonathan N Glickman, Robert D Odze, et al.
Digestive Diseases and Sciences|September 1, 2006
Obscure gastrointestinal hemorrhage from mesenteric varices diagnosed by video capsule endoscopyOren K Fix, Jonathan T Simon, Francis A Farraye, et al.
Inflammatory Bowel Diseases|January 24, 2018
Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab TherapyPerry K Pratt, Nunes David, Horst C Weber, et al.
Pageof 44

Showing results (301-310 of 432) with videos related to

Sort By:
Pageof 44
Annals of Gastroenterology|July 3, 2023
Association of serum IgG4 and disease outcomes in patients with inflammatory bowel diseaseR Christopher Chase, Hani Tamim, Walaa G El Sheikh, et al.
Gastro Hep Advances|September 23, 2024
Frailty and Inflammatory Bowel Disease: A Nationwide AssessmentYassine Kilani, Saqr Alsakarneh, Mohammad Aldiabat, et al.
Digestive Diseases and Sciences|June 14, 2025
Patients with Crohn's Disease and Ileostomy Can Respond to UpadacitinibLauren Loeb, Francis A Farraye, Sheena Crosby, et al.
The American Journal of Gastroenterology|February 6, 2024
Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial VirusRyan A Smith, Aakash Desai, Edward L Barnes, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 20, 2011
Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosisMelanie L Gainsbury, Daniel I Chu, Lauren A Howard, et al.
The American Journal of Surgical Pathology|March 27, 2004
Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findingsJonathan N Glickman, Athos Bousvaros, Francis A Farraye, et al.
Alimentary Pharmacology & Therapeutics|June 24, 2021
The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programmeFrancis A Farraye, Taha Qazi, Paulo G Kotze, et al.
Cancer|August 14, 2002
Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escapeWolfram V Bernstorff, Jonathan N Glickman, Robert D Odze, et al.
Digestive Diseases and Sciences|September 1, 2006
Obscure gastrointestinal hemorrhage from mesenteric varices diagnosed by video capsule endoscopyOren K Fix, Jonathan T Simon, Francis A Farraye, et al.
Inflammatory Bowel Diseases|January 24, 2018
Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab TherapyPerry K Pratt, Nunes David, Horst C Weber, et al.
Pageof 44